Cubist Systematic Strategies’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-154,512
Closed -$3.9M 1576
2024
Q4
$3.9M Buy
+154,512
New +$3.9M 0.02% 422
2024
Q2
Sell
-67,434
Closed -$2.83M 1641
2024
Q1
$2.83M Buy
+67,434
New +$2.83M 0.02% 735
2023
Q3
Sell
-11,460
Closed -$389K 2066
2023
Q2
$389K Buy
11,460
+8,678
+312% +$294K ﹤0.01% 1486
2023
Q1
$100K Buy
2,782
+1,226
+79% +$44.1K ﹤0.01% 2405
2022
Q4
$69.4K Buy
1,556
+1,547
+17,189% +$69K ﹤0.01% 2901
2022
Q3
$0 Buy
+9
New ﹤0.01% 3642
2022
Q2
Sell
-12,633
Closed -$430K 3837
2022
Q1
$430K Sell
12,633
-16,353
-56% -$557K ﹤0.01% 2602
2021
Q4
$1.12M Buy
28,986
+7,063
+32% +$273K 0.01% 1835
2021
Q3
$1.18M Sell
21,923
-972
-4% -$52.5K 0.01% 1389
2021
Q2
$766K Sell
22,895
-2,206
-9% -$73.8K 0.01% 1739
2021
Q1
$517K Buy
+25,101
New +$517K 0.01% 1936
2018
Q2
Sell
-6,134
Closed -$214K 1819
2018
Q1
$214K Buy
6,134
+3,141
+105% +$110K 0.01% 1358
2017
Q4
$128K Buy
2,993
+641
+27% +$27.4K 0.01% 1648
2017
Q3
$101K Buy
+2,352
New +$101K 0.01% 1626
2017
Q1
Sell
-854
Closed -$45K 1655
2016
Q4
$45K Sell
854
-921
-52% -$48.5K ﹤0.01% 1591
2016
Q3
$108K Buy
1,775
+398
+29% +$24.2K 0.01% 1446
2016
Q2
$91K Buy
+1,377
New +$91K 0.01% 1523
2016
Q1
Sell
-726
Closed -$171K 1632
2015
Q4
$171K Sell
726
-2,042
-74% -$481K 0.01% 1403
2015
Q3
$438K Buy
2,768
+2,141
+341% +$339K 0.02% 1035
2015
Q2
$237K Sell
627
-902
-59% -$341K 0.01% 1351
2015
Q1
$639K Buy
+1,529
New +$639K 0.03% 792
2014
Q3
Sell
-1,009
Closed -$247K 1746
2014
Q2
$247K Buy
+1,009
New +$247K 0.01% 1048